Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-30101719

ABSTRACT

BACKGROUND: There is a growing interest in the effects of probiotics for the prevention and treatment of skin diseases due to their immunomodulatory and antiinflammatory properties. OBJECTIVE: To assess a mixture of five bacterial strains in the prevention of chronic skin inflammation in mice. METHODS: Hairless SKH-1 mice received daily oral treatment with the probiotic mixture at the dose of 1x109 Colony-Forming Unit (CFU)/day (or vehicle) for three weeks. Chronic skin inflammation was induced by repeated applications of 12-O-tetradecanoylphorbol-13- acetate (TPA; control mice received acetone). Macroscopic and microscopic evaluations of skin lesions were performed and serum levels of interleukin (IL)-1ß, IL-6, tumor necrosis factor (TNF)-α, IL-17, IL-22, IL-10 and IL-4 measured at the end of the study. RESULTS: Treatment with the probiotic mixture significantly limited the induced chronic skin inflammation at both the macroscopic and microscopic levels. This limitation was consistent with downregulated levels of pro-inflammatory cytokines (IL-1ß, IL-6, TNF-α, IL- 17 and IL-22) and up-regulated levels of the anti-inflammatory cytokines, IL-10 and IL-4. CONCLUSION: The results suggest that the probiotic mixture tested could help in preserving skin integrity and homeostasis and that its use could be beneficial in dermatological conditions such as atopic dermatitis and psoriasis.


Subject(s)
Bifidobacterium longum/physiology , Dermatitis, Atopic/prevention & control , Lactobacillus/physiology , Lactococcus lactis/physiology , Probiotics/administration & dosage , Skin/microbiology , Streptococcus thermophilus/physiology , Administration, Oral , Animals , Chronic Disease , Cytokines/blood , Cytokines/immunology , Dermatitis, Atopic/chemically induced , Dermatitis, Atopic/immunology , Dermatitis, Atopic/microbiology , Disease Models, Animal , Female , Inflammation Mediators/blood , Inflammation Mediators/immunology , Lactobacillus helveticus/physiology , Lacticaseibacillus rhamnosus/physiology , Mice, Hairless , Skin/immunology , Tetradecanoylphorbol Acetate
2.
Benef Microbes ; 9(2): 299-309, 2018 Feb 27.
Article in English | MEDLINE | ID: mdl-29409331

ABSTRACT

Oral probiotics potential for the management of dermatological diseases is vast. However, results of available studies in skin diseases, such as atopic dermatitis (AD), are inconsistent, partly because probiotic effects are strain specific. Careful selection of probiotic strains is therefore indispensable to ensure efficacy of treatment. In this study, Lactobacillus salivarius LA307, Lactobacillus rhamnosus LA305 and Bifidobacterium bifidum PI22, three strains that were previously identified for their interesting immunomodulatory properties in allergy and/or colitis models, were assessed in the prevention of chronic skin inflammation induced by repeated applications of 12-O-tetradecanoylphorbol-13-acetate in hairless SKH-1 mice. Macroscopic and microscopic evaluation of skin lesions was performed together with measurements of serum levels of interleukin (IL)-1ß, IL-6, tumour necrosis factor alpha (TNF-α), IL-17, IL-22, IL-10 and IL-4. Daily oral treatment with the three strains at the dose of 1×109 cfu/day for 3 weeks limited the development of chronic skin inflammation, the effects being strain dependent. Indeed the two Lactobacillus strains significantly limited the intensity of skin inflammation both at the macroscopic and microscopic levels. Macroscopic observations were correlated to the histological observations and the resulting microscopic score. This limitation of the development of AD-like skin lesions involved the modulation of cytokine production. Treatment with the two Lactobacillus strains induced a decrease in the serum levels of pro-inflammatory cytokines IL-1ß, IL-6, TNF-α, IL-17, IL-22 and at the opposite an increase in the production of the anti-inflammatory cytokine IL-10 and also of IL-4. Globally, B. bifidum PI22 had lower benefits. These results obtained in mice suggest that L. salivarius LA307 and L. rhamnosus LA305 could be good candidates for preserving skin integrity and homeostasis via the modulation of the gut microbiota and that their use could be beneficial in dermatological conditions such as AD.


Subject(s)
Dermatitis, Atopic/drug therapy , Lacticaseibacillus rhamnosus/physiology , Ligilactobacillus salivarius/physiology , Probiotics/therapeutic use , Animals , Bifidobacterium/physiology , Cytokines/blood , Dermatitis, Atopic/chemically induced , Dermatitis, Atopic/pathology , Dermatitis, Atopic/prevention & control , Disease Models, Animal , Female , Immunomodulation , Mice , Mice, Hairless , Probiotics/administration & dosage , Tetradecanoylphorbol Acetate
3.
Behav Brain Res ; 261: 8-16, 2014 Mar 15.
Article in English | MEDLINE | ID: mdl-24333542

ABSTRACT

Methyl donor deficiencies and chronic stress cause depression independently, but their interaction has never been thoroughly evaluated. In our study, methyl donor deficient diet and chronic stress condition consisted respectively of a B2, B9, B12, and choline-free diet and a chronic mild stress procedure. Rats were randomly assigned to six groups with three "diet" conditions (free-feeding, pair-fed and methyl donor deficient diet) and two "stress" conditions (no-stress and stress) and were evaluated in the open-field, the elevated plus-maze and the forced swimming test. After the behavioral evaluation, corticosterone and homocysteine plasma levels were measured and dopamine, DOPAC, serotonin, 5HIAA concentrations were evaluated in several brain areas. Rats given a methyl donor deficient diet for 11 weeks causing elevated plasma homocysteine levels were compared to pair-fed and free-feeding rats with or without unpredictable chronic mild stress. Regardless of stress environmental conditions, the methyl donor deficient diet decreased plasma corticosterone levels and caused disinhibition in the elevated plus-maze condition relative to both control groups. However, stress potentiated the effects of the deficient regimen on rearing in the open-field and climbing in the forced swim test. The dietary changes involved in behavior and plasma corticosterone could be caused by homocysteine-induced decreases in dopamine and 5-hydroxytryptamine metabolites in selective brain regions and it can be noted that regardless of stress-conditions, methyl donor deficient diet decreases DOPAC/dopamine and 5HIAA/serotonin ratios in striatum and hypothalamus and selectively 5HIAA/serotonin ratio in the sensorimotor cortex. Our experimental data is particularly relevant in the context of neuropsychiatric disorders frequently associated with folate deficiency and hyperhomocysteinemia.


Subject(s)
Choline Deficiency/complications , Choline Deficiency/metabolism , Folic Acid Deficiency/complications , Folic Acid Deficiency/metabolism , Stress, Psychological/etiology , Analysis of Variance , Animals , Biogenic Amines/metabolism , Brain/metabolism , Chronic Disease , Corticosterone/blood , Diet , Disease Models, Animal , Exploratory Behavior/physiology , Homocysteine/blood , Maze Learning/physiology , Rats , Rats, Wistar , Spinal Cord/metabolism , Stress, Psychological/blood , Stress, Psychological/pathology , Swimming/psychology
4.
J Physiol Pharmacol ; 61(4): 483-90, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20814077

ABSTRACT

Human opiorphin QRFSR-peptide protects enkephalins from degradation by human neutral endopeptidase (hNEP) and aminopeptidase-N (hAP-N) and inhibits pain perception in a behavioral model of mechanical acute pain (1). Here, using two other pain rat models, the tail-flick and the formalin tests, we assess the potency and duration of the antinociceptive action of opiorphin with reference to morphine. The occurrence of adverse effects with emphasis on the side-effect profile at equi-analgesic doses was compared. We demonstrate that opiorphin elicits minimal adverse morphine-associated effects, at doses (1-2 mg/kg, i.v.) that produce a comparable analgesic potency in both spinally controlled thermal-induced acute and peripheral chemical-induced tonic nociception. The analgesic response induced by opiorphin in the formalin-induced pain model preferentially requires activation of endogenous mu-opioid pathways. However, in contrast to exogenous mu-opioid agonists such as morphine, opiorphin, does not develop significant abuse liability or antinociceptive drug tolerance after subchronic treatment. In addition, anti-peristaltism was not observed. We conclude that opiorphin, by inhibiting the destruction of endogenous enkephalins, which are released according to the painful stimulus, activates restricted opioid pathways specifically involved in pain control, thus contributing to a greater balance between analgesia and side-effects than found with morphine. Therefore, opiorphin could give rise to new analgesics endowed with potencies similar to morphine but with fewer adverse effects than opioid agonists. Its chemical optimization, to generate functional derivatives endowed with better bioavailability properties than the native peptide, could lead to a potent class of physiological type analgesics.


Subject(s)
Analgesics, Opioid/administration & dosage , Behavior, Addictive , Drug Tolerance/physiology , Oligopeptides/administration & dosage , Pain Measurement/drug effects , Salivary Proteins and Peptides/administration & dosage , Analgesics, Opioid/adverse effects , Animals , Behavior, Addictive/chemically induced , Dose-Response Relationship, Drug , Humans , Male , Oligopeptides/adverse effects , Pain Measurement/methods , Rats , Rats, Wistar , Salivary Proteins and Peptides/adverse effects
5.
J Food Sci ; 72(3): S203-6, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17995815

ABSTRACT

The preventive effects of ACTICOA powder (AP), a cocoa polyphenolic extract, on free radicals produced by leucocytes in rats after heat exposure (HE) and its protective effects on subsequent cognitive impairments were assessed. AP or vitamin E, the antioxidant reference, was orally administered to rats for 14 d before HE at 40 degrees C temperature during 2 h. The day after HE, free radical production by leucocytes in rats treated with AP or vitamin E was significantly reduced as compared to control. Unlike controls, AP- and vitamin E-treated rats discriminated between active lever and inactive levers in a light extinction paradigm. In the Morris water maze, escape latencies before reaching the hidden platform by AP- and vitamin E-treated rats decreased throughout testing. The daily oral administration of AP or vitamin E protected rats from cognitive impairments after HE by counteracting the overproduction of free radicals.


Subject(s)
Antioxidants/pharmacology , Cacao/chemistry , Cognition/drug effects , Free Radicals/metabolism , Hot Temperature , Leukocytes/drug effects , Administration, Oral , Animals , Cognition/physiology , Flavonoids , Leukocytes/metabolism , Male , Phenols , Polyphenols , Random Allocation , Rats , Rats, Wistar , Vitamin E/pharmacology
6.
Opt Express ; 14(8): 3304-11, 2006 Apr 17.
Article in English | MEDLINE | ID: mdl-19516473

ABSTRACT

Placing a Brewster-angle axicon inside a laser resonator makes it possible to produce a radially-polarized (RP) oscillation pattern distributed on a thin ring or a portion of a ring. Laser-diode end-pumped, Nd:Y(3)Al(5)O(12) and Nd:YVO(4) lasers were studied. Spatially coherent RP beams distributed on circular arcs were obtained with a polarization contrast ratio up to 80:1. Incoherent RP outputs on a full ring were also produced with a polarization contrast ratio of about 5:1. Applications of these beams to increase absorption efficiency in laser-matter interaction are discussed.

7.
Article in English | MEDLINE | ID: mdl-10063440

ABSTRACT

Photochemotherapy (PCT) consists in administration of a photosensitizer and subsequent irradiation of the tumor with visible light. Routinely, the photosensitizer is given intravenously (i.v.), but the major drawback of this procedure is the resulting skin photosensitivity. The goal of our study is to examine whether intravesical (i.b.) instillation of the photosensitizer for PDT of bladder cancer might be feasible in order to target the tumors and to avoid the photosensitization phenomenon. After first studying the biodistribution of hematoporphyrin derivative (HpD) in vivo in the rat bladder, two and four hours after intravesical administration, by fluorescence microscopy, we compared two different methods for the induction of superficial bladder tumors in rats with AY-27 tumor cell line in order to perform the same study on bladder tumors. The best results for the penetration depth of HpD in the normal bladder wall were obtained two hours after the bladder instillation where the photosensitizer was detected only in the bladder surface (urothelium and small part of the chorion). That's why we must choose the most appropriate bladder tumor model in order to obtain superficial bladder tumors that mimic the clinical behavior of superficial bladder cancer in man. Both techniques used in this study gave a high tumor take rate in a short time (> 90%). But we really obtained superficial bladder tumors directly attached to the bladder surface with one of the two methods of tumor induction consisting in the abrasion of the bladder surface prior to the administration of the tumoral cells in the bladder cavity.


Subject(s)
Hematoporphyrins/pharmacokinetics , Photochemotherapy/methods , Urinary Bladder Neoplasms/metabolism , Animals , Disease Models, Animal , Female , Hematoporphyrins/therapeutic use , Hemoglobins , Microscopy, Fluorescence , Rats , Rats, Inbred F344 , Urinary Bladder Neoplasms/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...